Skip to content
10-Q

Quarterly Report

SAB Biotherapeutics, Inc. SABS SABSW

0001193125-25-280572

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 47.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 77.86M sh
Shares Diluted Q3 2025 · Sep 30, 2025 30.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 9.26M sh
Shares Diluted Q3 2025 · Sep 30, 2024 9.25M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$28M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$24.76M
Short Term Investments Q3 2025 · Sep 30, 2025 $81.46M
Short Term Investments Q3 2025 · Dec 31, 2024 $11.86M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $29.42M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $8.9M
Stockholders Equity Q3 2025 · Sep 30, 2025 $165.07M
Stockholders Equity Q3 2025 · Jun 30, 2025 $12.02M
Stockholders Equity Q3 2025 · Mar 31, 2025 $21.41M
Stockholders Equity Q3 2025 · Dec 31, 2024 $25.97M
Stockholders Equity Q3 2025 · Sep 30, 2024 $36.9M
Stockholders Equity Q3 2025 · Jun 30, 2024 $46.12M
Stockholders Equity Q3 2025 · Mar 31, 2024 $52.82M
Stockholders Equity Q3 2025 · Dec 31, 2023 $57.3M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.79M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.98M
Total Liabilities Q3 2025 · Sep 30, 2025 $18.37M
Total Liabilities Q3 2025 · Dec 31, 2024 $18.23M
Current Assets Q3 2025 · Sep 30, 2025 $113.28M
Current Assets Q3 2025 · Dec 31, 2024 $23.79M
Total Assets Q3 2025 · Sep 30, 2025 $183.45M
Total Assets Q3 2025 · Dec 31, 2024 $44.2M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.12
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.45
Eps Basic Q3 2025 · Sep 30, 2025 $0.50
Eps Basic Q3 2025 · Sep 30, 2025 $0.73
Eps Basic Q3 2025 · Sep 30, 2024 −$1.12
Eps Basic Q3 2025 · Sep 30, 2024 −$2.45
Sga Expense Q3 2025 · Sep 30, 2025 $3.71M
Sga Expense Q3 2025 · Sep 30, 2025 $9.56M
Sga Expense Q3 2025 · Sep 30, 2024 $3.48M
Sga Expense Q3 2025 · Sep 30, 2024 $11.51M
Rd Expense Q3 2025 · Sep 30, 2025 $8.97M
Rd Expense Q3 2025 · Sep 30, 2025 $23.62M
Rd Expense Q3 2025 · Sep 30, 2024 $7.83M
Rd Expense Q3 2025 · Sep 30, 2024 $22.6M
Net Income Q3 2025 · Sep 30, 2025 $45.45M
Net Income Q3 2025 · Sep 30, 2025 $30.13M
Net Income Q3 2025 · Jun 30, 2025 −$10.11M
Net Income Q3 2025 · Mar 31, 2025 −$5.2M
Net Income Q3 2025 · Sep 30, 2024 −$10.35M
Net Income Q3 2025 · Sep 30, 2024 −$22.71M
Net Income Q3 2025 · Jun 30, 2024 −$7.34M
Net Income Q3 2025 · Mar 31, 2024 −$5.03M
Operating Income Q3 2025 · Sep 30, 2025 −$12.68M
Operating Income Q3 2025 · Sep 30, 2025 −$33.18M
Operating Income Q3 2025 · Sep 30, 2024 −$11.31M
Operating Income Q3 2025 · Sep 30, 2024 −$32.9M
Capex Q3 2025 · Sep 30, 2024 $281.89K
Revenue Q3 2025 · Sep 30, 2024 $1.21M